Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aralez Pharmaceuticals Inc (ARZ.TO)

Aralez Pharmaceuticals Inc (ARZ.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aralez Pharmaceuticals Inc 7100 West Credit Avenue Suite 101 Mississauga ON L5N 0E4 CAN

P: 905-876-1118

Description:

Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its revenue from the United States.

Key Statistics

Overview:

Market Capitalization, $K 2,016
Shares Outstanding, K 67,194
Annual Sales, $ 0 K
Annual Net Income, $ 0 K
60-Month Beta 1.45
% of Institutional Shareholders 7.00%

Growth:

1-Year Return -69.50%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 81.70%

Per-Share Information:

Latest Earnings Date 09/19/18
Earnings Per Share ttm -1.76
Most Recent Dividend 0.020 on 09/14/99
Next Ex-Dividends Date 09/14/99
Dividend Payable Date 12/31/69
Dividend Payout Ratio 0.00%

ARZ.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -262.08%
Return-on-Assets % -23.69%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share N/A
Interest Coverage N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar